Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Clinical trial NCT07055412 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07055412
Sponsor: Neurodawn Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetic Differences Y-3 Saftey Mild Hepatic Insufficiency Moderate Hepatic Insufficiency Normal Hepatic Function

Start date: 2025-07-10
Primary completion: 2025-10-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.